By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “BICILLIN” by Matthew A. Pater, representing Pfizer. This application was made available to the public on June 30, 2014 (see also Trademarks).
The international trademark goods and services class code for this trademark application is 005.
The serial number for this application is 78284102.
As submitted by the applicant, this trademark application relates to the following goods and services: Dibenzylethylenediamine dipencillin.
The owner/registrar information for this application is: Matthew A. Pater, Pfizer, 235 East 42nd Street, New York NY 10017.
Keywords for this news article include: Pharmaceutical Companies, Pfizer, Trademarks.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Read Next
